A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.